Coa and coworkers reported that IDO inhibition via Danshensu—a bioactive component isolated from Danshen—reduced liver fibrosis in CCl4-treated rats and hepatic stellate cells exposed to TGF-β [27]. Here, TGFB1 is linked to Hepatic fibrosis.